Steven Tignor, Merck & Co., Inc. - Qepler Summits And Conferences

Steven Tignor

Senior Scientist
Merck & Co., Inc.
New York, USA
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.

Steven Tignor is a Senior Scientist in Analytical Research & Development at Merck. He received his Bachelor's Degree in Chemistry and Physics from Rensselaer Polytechnic Institute in 2016 studying material properties and degradation pathways of fuel cell materials and his Ph.D. in Chemistry from Princeton University in 2020 studying novel organometallic electrocatalysis mechanisms.

Since beginning at Merck in 2020 he has led several efforts in understanding nitrosamine formation and inhibition within drug products. His research interests range synthetic organic chemistry, analytical chemistry, and materials science. Currently, Steven is heavily involved in both drug substance and drug product development at Merck, contributing significantly to internal impurity risk assessments, CMC authoring, and regulatory interactions.

Related Sessions:

3rd Annual Genotoxic Impurities
in Pharmaceuticals Summit 2023

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 09 Mar 2023
  • Virtual,
  • Pharma
Day 1: Thursday, 09 March 2023
CASE STUDY: Inhibition of Nitrosamine Formation in Drug Products
  • Nitrosamine formation in drug products can be mitigated through the use of inhibitors
  • Formulation processing can significantly impact the efficiency of inhibitors in OSDs
  • Understanding the benefits and limitations of model compounds used in the solid state
View Details